← Home
/
ADIAL PHARMACEUTICALS, INC. (ADIL)
Stock Analysis
ADIAL PHARMACEUTICALS, INC. (ADIL)
ADIL
ADIL · Market data
2.75
+8.27%
Updated: 2026-06-18 13:33 UTC
WOI Investment Thesis
Mixed
Confirmation improves above 5.09. Holding above 2.22 keeps the current thesis intact.
✓
Fundamentals
Insufficient / Insufficient
×
Breakout Confirmation
Pending
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
2.22
↗
Break Above
Confirmation improves above resistance.
5.09
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below 2.22
What's Driving ADIL?
📈 Technical recovery is improving
Momentum is Neutral. Watch 5.09 for confirmation and 2.22 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
Below 2.22
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
▲
No confirmed breakout yet. Watch the next level and momentum behavior.
Breakout Watch
Downtrend line not broken yet · score 0
◎
How to read this setup
The nearest decision zone is framed by support around 2.22 and resistance near 5.37. A cleaner push through resistance would improve continuation odds, while a loss of support would weaken the current thesis.
Business Lens
Financial context is mixed
Financial quality is mixed, with cash flow or balance sheet items requiring closer monitoring.
↗
Revenue Growth
Insufficient
●
Profitability
Insufficient
📈 Net Income
-2.02M
≈ Insufficient
🧮 EPS (Basic)
-1.48
≈ Insufficient
ADIAL PHARMACEUTICALS, INC.
Note: This is an algorithmic technical snapshot, not financial advice.